Serotonin–dopamine reuptake inhibitor
Class of drug / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Serotonin–dopamine reuptake inhibitor?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
A serotonin–dopamine reuptake inhibitor (SDRI) is a type of drug which acts as a reuptake inhibitor of the monoamine neurotransmitters serotonin and dopamine by blocking the actions of the serotonin transporter (SERT) and dopamine transporter (DAT), respectively. This in turn leads to increased extracellular concentrations of serotonin and dopamine, and, therefore, an increase in serotonergic and dopaminergic neurotransmission.
A closely related type of drug is a serotonin–dopamine releasing agent (SDRA).